Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumor of Bone”

1,029 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,029 results

Not applicableStudy completedNCT02192333
What this trial is testing

Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

Who this might be right for
Breast CarcinomaCancer SurvivorDepression+10 more
Fred Hutchinson Cancer Center 390
Testing effectiveness (Phase 2)UnknownNCT00180947
What this trial is testing

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

Who this might be right for
RhabdomyosarcomasNeoplasms, Connective and Soft TissueEwing Tumor+3 more
Gustave Roussy, Cancer Campus, Grand Paris 210
Not applicableNot Yet RecruitingNCT03359304
What this trial is testing

The Neurofibromatosis-associated Tumor Biobank

Who this might be right for
Neurofibromatoses
Ren tingting 300
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Not applicableUnknownNCT04867421
What this trial is testing

Neutrophils in Bone Sarcomas

Who this might be right for
Osteosarcoma, Chondrosarcoma
Université de Reims Champagne-Ardenne 25
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Post-approval studies (Phase 4)Ended earlyNCT00819832
What this trial is testing

Anderson Circulating Tumor Cell Burden (CTCB) Study

Who this might be right for
CancerSpinal DiseaseVertebral Compression Fractures
M.D. Anderson Cancer Center 3
Not applicableLooking for participantsNCT06486506
What this trial is testing

Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic Results

Who this might be right for
Bone TumorBone Cancer
Costantino Errani 150
Testing effectiveness (Phase 2)Looking for participantsNCT05642455
What this trial is testing

SPEARHEAD-3 Pediatric Study

Who this might be right for
Synovial SarcomaMalignant Peripheral Nerve Sheath Tumor (MPNST)Neuroblastoma (NBL)+1 more
USWM CT, LLC 20
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)Study completedNCT00004078
What this trial is testing

Irinotecan in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more
Children's Oncology Group 181
Large-scale testing (Phase 3)Study completedNCT01137682
What this trial is testing

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 198
Not applicableNot Yet RecruitingNCT05616182
What this trial is testing

Application of LARS Ligament in Bone Prosthesis Replacement

Who this might be right for
Malignant Tumor
Henan Cancer Hospital 100
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT03160079
What this trial is testing

Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Adult
University of California, San Diego 16
Not applicableStudy completedNCT00007046
What this trial is testing

Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone

Who this might be right for
StenosisHistiocytoma
National Center for Research Resources (NCRR)
Post-approval studies (Phase 4)Study completedNCT00376064
What this trial is testing

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Study completedNCT00003406
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Cancer Treatment Centers of America 30
Load More Results